Cargando…
Nanodrugs Reprogram Cancer-Associated Fibroblasts and Normalize Tumor Vasculatures for Sequentially Enhancing Photodynamic Therapy of Hepatocellular Carcinoma
BACKGROUND: The failure of cancer photodynamic therapy (PDT) is largely ascribed to excessive stroma and defective vasculatures that restrain the photosensitizer permeation and the oxygen perfusion in tumors. METHOD AND RESULTS: In this study, a nanodrug that integrated the cancer-associated fibrobl...
Autores principales: | Fei, Bingyuan, Mo, Zhanhao, Yang, Jinghui, Wang, Zheng, Li, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638926/ https://www.ncbi.nlm.nih.gov/pubmed/37954460 http://dx.doi.org/10.2147/IJN.S429884 |
Ejemplares similares
-
Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature
por: Chou, Cheng-Ying, et al.
Publicado: (2017) -
Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment
por: Zhu, Ting, et al.
Publicado: (2019) -
Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles
por: Zhen, Zipeng, et al.
Publicado: (2014) -
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
por: Katopodi, Theodora, et al.
Publicado: (2023) -
Hybrid Inorganic-Organic Core-Shell Nanodrug Systems in Targeted Photodynamic Therapy of Cancer
por: Matlou, Gauta Gold, et al.
Publicado: (2021)